Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives

BACKGROUND: Availability of tumor material at baseline and disease progression is increasingly important for patient management in non-small-cell lung cancer (NSCLC), especially for the application of targeted therapies like tyrosine kinase inhibitors and for immune checkpoint inhibitor treatment. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wessels, Sabine, Muley, Thomas, Christopoulos, Petros, Meister, Michael, Heinzmann-Groth, Ingrid, Warth, Arne, Herpel, Esther, Hummler, Simone, Klingmüller, Ursula, Kuon, Jonas, Heussel, Claus-Peter, Eberhardt, Ralf, Herth, Felix J. F., Winter, Hauke, Bischoff, Helge, Stenzinger, Albrecht, Reck, Martin, Huber, Rudolf Maria, Thomas, Michael, Schneider, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481602/
https://www.ncbi.nlm.nih.gov/pubmed/32953480
http://dx.doi.org/10.21037/tlcr-20-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481602/
https://www.ncbi.nlm.nih.gov/pubmed/32953480
http://dx.doi.org/10.21037/tlcr-20-137

Ejemplares similares